Saskatchewan Cancer Agency

300 300 Princess Margaret Cancer Care Network

The Saskatchewan Cancer Agency (SCA) is a provincial healthcare organization with a vision to see a healthy population free from cancer. SCA provides leadership in health promotion, early detection, treatment and research for cancer.

Nearly 1,000 dedicated SCA staff work together to provide high quality, safe and supportive patient and family-centered care at two cancer centres in Regina and Saskatoon, as well as in rural communities in partnership with hospitals through the Community Oncology Program of Saskatchewan. The Cancer Agency also manages two patient lodges in Regina and Saskatoon to provide a home away from home for rural patients, so they do not have to travel long distances for treatment.

SCA Radiation Oncology programs include:

  • All standard External Beam Radiation Treatments (EBRT), Gynecological Intracavitary Brachytherapy program, Stereotactic Body Radiation Therapy (SBRT) program for Lung, Bone, Spine, and Lymph nodes, and Stereotactic Radiosurgery (SRS) for Intracranial Lesions;
  • Other programs catering to the whole province include Prostate Brachytherapy and Gynecological Interstitial Brachytherapy;
  • More programs are currently in development, including Liver, Pancreas, and Renal Stereotactic Body Radiation Therapy. These programs are expected to become fully established by 2026.

Malignant Hematology and General Hematology programs catering to the whole province include:

  • Both Allogeneic and Autologous Bone Marrow Transplant programs
  • CAR-T cell treatment;
  • Bleeding disorder program;
  • Cancer Associated Thrombosis program; and
  • Monoclonal Gammopathies management program.

In the past 4 years, we moved to Disease Site Specific Clinic model, which created all four major sites (Breast, Prostate, Genitourinary, Gastrointestinal) and other minor sites. Each site has provincial chair and Multidisciplinary Tumor rounds.

The Cancer Agency also operates prevention and early detection programs, including screening programs for breast, cervical and colorectal cancers to help detect cancer in its earliest stages. Finally, the SCA is proud to conduct innovative research performed by world-class scientists and researchers who provide laboratory, epidemiological and clinical research, including clinical trials.

Privacy Preferences

When you visit our website, it may store information through your browser from specific services, usually in the form of cookies. Here you can change your Privacy preferences. It is worth noting that blocking some types of cookies may impact your experience on our website and the services we are able to offer.

Click to enable/disable Google Analytics tracking code.
Click to enable/disable Google Fonts.
Click to enable/disable Google Maps.
Click to enable/disable video embeds.
Our website uses cookies, mainly from 3rd party services. Define your Privacy Preferences and/or agree to our use of cookies.